YU23099A - Pharmaceutical compositions containing n-sulphonyl indolin derivatives - Google Patents

Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Info

Publication number: YU23099A
Authority: YU; Yugoslavia
Prior art keywords: amphiphilic; ionic hydrophilic; sulphonyl; pharmaceutical compositions; compositions containing
Prior art date: 1996-12-05

Application number

YU23099A

Other languages

English (en)

Serbo-Croatian (sh)

Serbian (sr)

Inventor

Jean-Claude Gautier

Simon John Fuller

Original Assignee

Sanofi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-05

Filing date

1999-05-26

Publication date

1999-11-22

1999-05-26 Application filed by Sanofi filed Critical Sanofi

1999-11-22 Publication of YU23099A publication Critical patent/YU23099A/sr

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
150000002433 hydrophilic molecules Chemical class 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000007928 solubilization Effects 0.000 abstract 1
238000005063 solubilization Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

YU23099A 1996-12-05 1999-05-26 Pharmaceutical compositions containing n-sulphonyl indolin derivatives YU23099A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9614957A FR2756736B1 (fr)	1996-12-05	1996-12-05	Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number	Publication Date
YU23099A true YU23099A (en)	1999-11-22

Family

ID=9498376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
YU23099A YU23099A (en)	1996-12-05	1999-05-26	Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Country Status (25)

Country	Link
EP (1)	EP0941090A1 (fr)
JP (1)	JP2000507618A (fr)
KR (1)	KR20000069308A (fr)
CN (1)	CN1239887A (fr)
AR (1)	AR009651A1 (fr)
AU (1)	AU716575B2 (fr)
BR (1)	BR9712406A (fr)
CA (1)	CA2273990A1 (fr)
CO (1)	CO4910129A1 (fr)
DZ (1)	DZ2362A1 (fr)
EE (1)	EE9900206A (fr)
FR (1)	FR2756736B1 (fr)
HU (1)	HUP0001386A3 (fr)
ID (1)	ID23373A (fr)
IL (1)	IL129936A0 (fr)
IS (1)	IS5062A (fr)
MY (1)	MY132819A (fr)
NO (1)	NO992724L (fr)
NZ (1)	NZ335750A (fr)
RU (1)	RU2174394C2 (fr)
SK (1)	SK75599A3 (fr)
TR (1)	TR199901702T2 (fr)
WO (1)	WO1998024430A1 (fr)
YU (1)	YU23099A (fr)
ZA (1)	ZA9710919B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786486B3 (fr) *	1998-11-16	2000-12-08	Sanofi Sa	Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) *	1999-03-25	2000-09-28	Basf Ag	Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en)	1999-09-27	2002-08-20	American Cyanamid Company	Pharmaceutical carrier formulation
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
WO2001034119A2 (fr)	1999-11-12	2001-05-17	Abbott Laboratories	Inhibiteurs de cristallisation dans une dispersion solide
FR2805992A1 (fr) *	2000-03-08	2001-09-14	Sanofi Synthelabo	Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de)	2000-05-30	2001-12-06	Basf Ag	Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) *	2001-06-26	2002-12-26	Farmatron Ltd	Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
UA119324C2 (uk) *	2013-04-02	2019-06-10	Теміс Медікер Лімітед	Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3237814A1 (de) *	1982-10-12	1984-04-12	Warner-Lambert Co., 07950 Morris Plains, N.J.	Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) *	1991-08-02	1993-12-03	Elf Sanofi	Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/fr not_active Expired - Fee Related
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/fr active
- 1997-12-04 CA CA002273990A patent/CA2273990A1/fr not_active Abandoned
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
- 1997-12-04 ID IDW990445D patent/ID23373A/id unknown
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/xx unknown
- 1997-12-04 EE EEP199900206A patent/EE9900206A/xx unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/ko not_active Ceased
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/ru active
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/hu unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/ja active Pending
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/es unknown
- 1997-12-04 CN CN97180304A patent/CN1239887A/zh active Pending
- 1997-12-04 AR ARP970105696A patent/AR009651A1/es unknown
- 1997-12-04 IL IL12993697A patent/IL129936A0/xx unknown
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/xx unknown
- 1997-12-04 EP EP97950228A patent/EP0941090A1/fr not_active Withdrawn
- 1997-12-04 SK SK755-99A patent/SK75599A3/sk unknown
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/fr not_active Ceased
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/pt unknown
1999
- 1999-05-26 YU YU23099A patent/YU23099A/sr unknown
- 1999-06-01 IS IS5062A patent/IS5062A/is unknown
- 1999-06-04 NO NO992724A patent/NO992724L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1998024430A1 (fr)	1998-06-11
ID23373A (id)	2000-04-20
FR2756736A1 (fr)	1998-06-12
NO992724D0 (no)	1999-06-04
RU2174394C2 (ru)	2001-10-10
TR199901702T2 (en)	1999-09-21
CA2273990A1 (fr)	1998-06-11
EP0941090A1 (fr)	1999-09-15
BR9712406A (pt)	1999-08-31
CN1239887A (zh)	1999-12-29
AR009651A1 (es)	2000-04-26
DZ2362A1 (fr)	2002-12-28
CO4910129A1 (es)	2000-04-24
SK75599A3 (en)	2000-08-14
IL129936A0 (en)	2000-02-29
AU5326298A (en)	1998-06-29
MY132819A (en)	2007-10-31
EE9900206A (et)	1999-12-15
NO992724L (no)	1999-06-04
NZ335750A (en)	2001-06-29
ZA9710919B (en)	1999-06-04
AU716575B2 (en)	2000-03-02
HUP0001386A2 (hu)	2001-04-28
JP2000507618A (ja)	2000-06-20
FR2756736B1 (fr)	1999-03-05
KR20000069308A (ko)	2000-11-25
IS5062A (is)	1999-06-01
HUP0001386A3 (en)	2002-03-28

Publication	Publication Date	Title
NO984790L (no)	1998-12-15	Midt-kjede forgrenede surfaktanter
DK0975235T4 (da)	2014-03-31	Ernæringssammensætninger indeholdende oligosaccharider
CA2316485A1 (fr)	1999-07-08	Compositions pharmaceutiques a liberation prolongee
DE3176125D1 (en)	1987-05-27	1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds
TNSN97056A1 (fr)	2005-03-15	Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant.
GB2396813A (en)	2004-07-07	Sunscreen compositions
ATE286500T1 (de)	2005-01-15	1,2,3,4-tetrahydroisochinolin-derivate
BR9914698A (pt)	2003-01-07	Composto que se liga a um receptor mp1, dìmero, métodos para aumentar megacariócitos ou plaquetas em um paciente com necessidade disto, e para produzir um composto, composição farmacêutica, polinucleotìdeo, vetor, e, célula hospedeira.
TNSN97015A1 (fr)	2005-03-15	Nouveaux derives de 19-nor-pregnene.
FR2686878B1 (fr)	1995-06-30	Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
TNSN99142A1 (fr)	2005-11-10	Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
BR9808396A (pt)	2000-05-23	Processo para aumentar a deposição de um agente benéfico de uma composição em barra, e, barra
NO20010833L (no)	2001-02-19	Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
AP1424A (en)	2005-06-06	2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
ATE254478T1 (de)	2003-12-15	Stabile zusammensetzungen enthaltend ein retinoid und ein antioxidierendes system auf enzymbasis
AU6202299A (en)	2000-05-22	Compositions for the treatment and prevention of neurological and pathopsychological diseases
ES2180591T3 (es)	2003-02-16	Barra limpiadora de la piel que tiene cocoil-isetionato de primera destilacion.
GB2329585A (en)	1999-03-31	A barrier cream comprising hexamethylenetetramine or derivative thereo
MY132819A (en)	2007-10-31	Pharmaceutical compositions containing n-sulphonylindoline derivatives
BR9811339A (pt)	2000-09-26	"composição de limpeza pessoal lìquida removìvel por enxaguamento"
JP2000026260A (ja)	2000-01-25	口腔用組成物
TNSN97156A1 (fr)	2005-03-15	Derives de pyrrolidinyl-et pyrrolinyl-ethylamine, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97173A1 (fr)	2005-03-15	Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.
AU2809697A (en)	1997-11-12	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
EP0389079A3 (fr)	1991-08-07	Polyamides portant des chaínes latérales fonctionnalisées utilisables comme agents hypolipidémiques solubles dans l'eau